Testing a new strep vaccine for safety and immune response
Part of Bones, joints & muscles, Heart & circulation, Infections, Skin clinical trials.
This study tests a new vaccine called StreptInCor that may help prevent rheumatic fever (a condition caused by strep infections that can damage the heart). It is an early trial to check if the vaccine is safe and produces a good immune response in healthy adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Be in good general health
- Be willing to attend all study visits
- Have no history of rheumatic fever, heart disease, or kidney problems
- Not be pregnant or planning to become pregnant
- Not have taken immune-suppressing medications in the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving penicillin to healthy school-aged children for a few years can prevent rheumatic heart disease, a serious heart condition that can start after a strep throat infection. If your child qualifies, they would receive free heart checks and treatment that could keep their heart healthy.
This study checks children aged 5–8 for early signs of rheumatic heart disease, a heart problem that can follow a strep throat infection. It aims to see how common it is in different parts of Africa to help prepare for a future vaccine. Children with a normal heart ultrasound at the start may join.
This trial tests different treatments for acute rheumatic fever with heart inflammation (carditis) to see if they can reduce damage to the heart valves after 6 months. It aims to find better ways to prevent long-term rheumatic heart disease.
This study tests the safety and immune response of a dengue vaccine in people aged 12–59 with stable autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are on low-dose or no immune-suppressing medications. It also includes healthy volunteers for comparison.
This trial tests a meningitis B vaccine (MenB-4C) in children and young adults with autoimmune rheumatic diseases. It aims to see if the vaccine is safe and works well for these patients.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
Hear when a new Rheumatic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.